| Reference Blogs | Publisher | issue date | about |
|
Points to consider for setting the remaining shelf-life of medical products upon delivery |
WHO | 2020 | Points to consider for setting the remaining shelf-life of medical products upon delivery |
|
WHO Technical Report Series, no. 1025: Good storage and distribution practices for medical products |
WHO | 2020 |
Good storage and distribution practices for medical products |
|
Quality management system requirements for national inspectorates |
WHO | 2020 | Quality management system requirements for national inspectorates |
|
WHO Technical Report Series, no. 1011: Guidelines on procedures and data requirements for changes to approved biotherapeutic products |
WHO | 2018 |
Guidelines on procedures and data requirements for changes to approved biotherapeutic products |
|
(WHO) Technical Report Series, No. 953, 2009 Stability testing of active pharmaceutical ingredients and |
WHO | 2018 | Stability testing of active pharmaceutical ingredients and finished pharmaceutical products |
|
WHO good practices for desk assessment of compliance with good manufacturing practices, good laboratory practices and good clinical practices for medical products regulatory decisions |
WHO | 2018 | WHO good practices for desk assessment of compliance with good manufacturing practices, good laboratory practices and good clinical practices for medical products regulatory decisions |
|
WHO good manufacturing practices for the manufacture of herbal medicines |
WHO | 2018 |
WHO good manufacturing practices for the manufacture of herbal medicines |
|
WHO good manufacturing practices for the manufacture of herbal medicines |
WHO | 2018 |
WHO good manufacturing practices for the manufacture of herbal medicines |
|
WHO guidance on good manufacturing practices: Model inspection report |
WHO | 2016 |
WHO guidance on good manufacturing practices: Model inspection report |
|
WHO Technical Report Series, no. 993: Guidelines on procedures and data requirements for changes to approved vaccines |
WHO | 2015 |
Guidelines on procedures and data requirements for changes to approved vaccines |
|
General guidance on hold-time studies
|
WHO | 2015 | General guidance on hold-time studies |
|
Technical supplements to Model guidance for the storage and transport of time- and temperature–sensitive pharmaceutical products |
WHO | 2015 | Technical supplements to Model guidance for the storage and transport of time- and temperature–sensitive pharmaceutical products |
|
WHO Technical Report Series, no. 992: TRS 992 Annex 9 Good review practices: guidelines for national and regional regulatory authorities |
WHO | 2015 |
General guidance on hold-time studies |
|
WHO good manufacturing practices for pharmaceutical products: Main principles |
WHO | 2014 | WHO good manufacturing practices for pharmaceutical products: Main principles |
|
WHO guidelines for drafting a site master file
|
WHO | 2011 | WHO guidelines for drafting a site master file |
|
Model guidance for the storage and transport of time and temperature sensitive pharmaceutical products |
WHO | 2011 |
Model guidance for the storage and transport of time and temperature sensitive pharmaceutical products |
|
WHO good manufacturing practices for sterile pharmaceutical products |
WHO | 2011 | WHO good manufacturing practices for sterile pharmaceutical products |
|
WHO good manufacturing practices for active pharmaceutical ingredients (bulk drug substances) |
WHO | 2010 | WHO good manufacturing practices for active pharmaceutical ingredients (bulk drug substances) |
|
WHO good manufacturing practices for pharmaceutical products containing hazardous substances |
منظمة الصWHOحة العالمية | 2010 | WHO good manufacturing practices for pharmaceutical products containing hazardous substances |
|
WHO good manufacturing practices for the manufacture of pharmaceutical excipients |
WHO | 1999 | WHO good manufacturing practices for the manufacture of pharmaceutical excipients |
|
WHO – guideline for safe disposal of unwanted pharmaceutical |
WHO | 1999 |
guideline for safe disposal of unwanted pharmaceutical |
|
Inspection of pharmaceutical manufacturers |
WHO | 1992 |
Inspection of pharmaceutical manufacturers |
|
WHO- management of waste from immunization campaign activities guideline |
WHO | 2004 |
management of waste from immunization campaign activities guideline |
|
WHO guidelines on pre-approval inspections
|
WHO | 2002 |
WHO guidelines on pre-approval inspections |
| الدليل الإرشادى الخاص بوزارة البيئة بشأن إدارة نفايات الرعاية الصحية فى مصر. | WHO | 2015 | إدارة نفايات الرعاية الصحية فى مصر |
Sorry, this website does not support this browser